Vandana Singh
·
September 8, 2025
Benzinga
Summit's ivonescimab showed improved survival trends in NSCLC patients with favorable safety, though some results missed statistical significance thresholds.
read more
September 5, 2025
August 18, 2025
Bloomberg
July 28, 2025
June 16, 2025
Fortune